Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer
The present invention provides MDM2 inhibitor compounds of Formula I,
Amgen INC.
A C C C C C C A C A C C C C C C C A C C C C A C A C A C C
A61P C07D C07D C07D C07D C07D C07D A61P C07D A61P C07D C07D C07D C07D C07D C07D C07D A61P C07D C07D C07D C07D A61P C07D A61P C07D A61P C07D C07D
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Michael W. Jason A. Yosup Yihong Michael G. Jeffrey Xiaoqi Jeffrey Thomas Benjamin Ana Julie A. SuJen Steven H. Joel Darin J. Jiang Richard Victor Xuelei Daqing Jiasheng David John Xin Zhihua Frank Zhihong Brian S. Jonathan D. Ming Felix Xiaodong Brian M. Lawrence R. John XianYun Dustin L. Hilary Plake Zice Philip M. Julio C. Michael D. Jiwen Yingcai
Gribble Duquette Rew Li Johnson Deignan Chen Mihalic Fisher Gonzalez Buenrostro Heath Lai Olson McIntosh Gustin Zhu Connors Yan Sun Fu Kopecky Huang Ma Kayser Li Lucas Low Yu Gonzalez Lopez De Turiso Wang Fox McGee Eksterowicz Jiao McMinn Beck Fu Roveto Medina Bartberger Liu Wang